Glaukos Corporation (GKOS) vs Insulet Corporation (PODD)
Glaukos Corporation and Insulet Corporation are both Medical Devices companies. Glaukos Corporation and Insulet Corporation are of similar size ($9.6B and $9.1B). Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Insulet Corporation trades at 25.4×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 29.4%. Insulet Corporation has the higher net margin (12.3% vs −30.7%) and the higher return on invested capital (17.6% vs −26.1%). Across the 19 metrics below, Insulet Corporation leads on 14 and Glaukos Corporation on 5.
Valuation
Profitability
| Metric | GKOS | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.12% | 71.07% | 56.01% |
| Operating margin | (31.55%) | 16.89% | (15.03%) |
| Net margin | (30.68%) | 12.29% | (20.40%) |
| Free cash flow margin | (1.99%) | 8.70% | (7.24%) |
| Return on equity | (25.98%) | 26.02% | (15.32%) |
| Return on assets | (19.72%) | 11.31% | (19.72%) |
| Return on invested capital | (26.07%) | 17.56% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack